Patient Centricity Archives - Insights From Our Labs to Yours

Three generation family looking at old photographs, laughing

How patient-centricity embeds value and stability in LTFU studies

by Labcorp Drug Developmentupdated on Wednesday, November 16, 2022Wednesday, November 16, 2022

Phase I-III randomized controlled trials alone are not generating enough data to extrapolate conclusions and theories about therapeutics to the global population. Not all drugs demonstrate the same efficacy in the real world as shown in the clinical trials. Because of this, we are seeing a rise in long-term follow-up …

Technologies, tools and processes to support patient-centric oncology trials

by Labcorp Oncologyupdated on Thursday, December 9, 2021Tuesday, December 7, 2021

There is a gap between the number of patients needed to participate in new cancer trials and the number who give consent to take part. Decentralized clinical trials (DCTs) are helping to address this gap by increasing the reach of clinical studies beyond conventional research sites. DCTs provide an opportunity …

Understanding the voice of pediatric patients during COVID-19

by Labcorp Drug Developmentupdated on Monday, June 7, 2021Monday, October 12, 2020

The COVID-19 pandemic forced a sudden shift in the conduct of clinical trials to ensure patients stay safe and retain access to their treatments. But how has this shift affected trials that focus on pediatric populations? To better understand the voice of pediatric patients, our team recently held an interactive, …

Patient-Centric Sampling Evolution

by Labcorp Drug Developmentupdated on Monday, June 7, 2021Monday, October 5, 2020

As the pharmaceutical industry continues to seek ways to increase efficiency in bringing life-saving treatments to the patients who need them, a focus on both the ethical and financial benefits of patient-centric sampling has intensified. In this blog, our Director of Bioanalytical Science, Stephanie Cape, PhD, discusses the benefits, evolution …

Building efficiencies into decentralized long-term follow-up studies

by Labcorp Drug Developmentupdated on Thursday, December 17, 2020Monday, July 13, 2020

As part of an ongoing effort to improve efficiencies and increase patient centricity, long-term follow up (LTFU) studies are increasingly using decentralized clinical trial (DCT) models and reducing the need for patients to visit physical investigator sites. While the prospects of cutting study costs and reducing patient burden are attractive, …

Inflammatory Bowel Disease clinical studies and the importance of patient centricity

by Martin Knight BScupdated on Monday, June 7, 2021Tuesday, June 9, 2020

In today’s exceptionally crowded clinical trial environment of inflammatory bowel disease (IBD), patient-centric practices can help your study of Crohn’s disease (CD) or ulcerative colitis (UC) stand out to both patients and sites. Learn about your options to increase your trial’s patient centricity, encourage recruitment and promote ongoing patient retention. …

Incorporating the patient voice to improve ulcerative colitis recruitment

by Joan Meyer, Ph.D.updated on Monday, June 7, 2021Sunday, March 29, 2020

The exact cause of ulcerative colitis (UC) is still unknown, but approximately 700,000 people in the United States suffer from this chronic, life-long disease that causes inflammation in the large intestine. A wide range of treatment options are available, but drug development sponsors are seeking additional ways to control inflammation, …

Fixing the patient recruitment “leaky funnel”: blending data with a patient and site-centric approach to address the challenge

by Ben Quartley, PhDupdated on Monday, June 7, 2021Tuesday, January 7, 2020

Most people in our industry are familiar with the “Leaky Funnel” analogy that describes the model where we approach a large number of patients for inclusion in a study, but they leak out of the pipe at every juncture. The loss of patients through planning, screening and execution of the …

Listening to – and learning from – the voice of the patient

by Greg Kline, Executive Director, Market and Patient Intelligenceupdated on Monday, June 7, 2021Tuesday, September 3, 2019

Patient recruitment represents the biggest challenge in clinical trials. From general patient identification and participation to reducing screen failure rate or limiting patient drop out after enrollment, drug developers face many massive pain points to initiate their clinical trials. Patient recruitment and retention continue to be the biggest challenge in …

Building awareness with National Diabetes Month and new T2DM treatment guidelines

by Barry J. Goldstein, MD, PhD, FACEupdated on Monday, June 7, 2021Tuesday, November 13, 2018

Coinciding with National Diabetes Month is the recent publication, Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), which contains the most up-to-date, impactful set of new treatment guidelines for patients with …